ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,304Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 617

$677K Total Retail Price of All Prescriptions

Rank: 30 out of 617

556 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 556 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 556 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 11,616 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 611 452 1 3
LEVOTHYROXINE SODIUM 597 530 2 1
HYDROCODONE-ACETAMINOPHEN 498 358 S3 3 8
SIMVASTATIN 457 396 4 2
FUROSEMIDE 425 357 5 4
WARFARIN SODIUM 305 267 6 7
AMLODIPINE BESYLATE 301 256 7 6
CITALOPRAM HBR 255 218 8 18
HYDROCHLOROTHIAZIDE 240 172 9 13
ZOLPIDEM TARTRATE 237 210 10 23
METOPROLOL SUCCINATE 234 213 11 12
METOPROLOL TARTRATE 234 215 11 11
TRAMADOL HCL 231 186 13 15
LISINOPRIL 227 168 14 5
GABAPENTIN 205 136 15 16
POTASSIUM CHLORIDE 188 160 16 10
ENALAPRIL MALEATE 176 160 17 34
FLUTICASONE PROPIONATE 170 119 18 36
FAMOTIDINE 164 116 19 54
ALLOPURINOL 163 130 20 27
CEFUROXIME 161 126 21 165
CARVEDILOL 161 115 21 19
MELOXICAM 154 132 23 24
POLYETHYLENE GLYCOL 3350 152 84 24 32
LOSARTAN POTASSIUM 148 147 25 22
PRAVASTATIN SODIUM 146 128 26 21
GLIMEPIRIDE 146 123 26 33
SERTRALINE HCL 145 108 28 20
NAMENDA 140 100 29 35
TAMSULOSIN HCL 132 93 30 26
PREDNISONE 131 114 31 31
FENTANYL 127 125 S2 32 45
RANITIDINE HCL 126 104 33 40
ATENOLOL 117 104 34 17
DIGOXIN 115 95 35 48
ATORVASTATIN CALCIUM 108 77 36 14
MIRTAZAPINE 105 92 37 50
METFORMIN HCL 101 70 38 9
SULINDAC 100 98 39 197
DIVALPROEX SODIUM ER 99 0 40 181
OXYBUTYNIN CHLORIDE ER 99 98 40 114
CLONIDINE HCL 97 84 42 55
DILTIAZEM ER 94 90 43 81
AMITRIPTYLINE HCL 90 71 R 44 56
CYCLOBENZAPRINE HCL 87 51 R 45 74
PANTOPRAZOLE SODIUM 82 71 46 37
OLANZAPINE 80 42 47 139
DONEPEZIL HCL 80 56 47 30
AZITHROMYCIN 80 61 47 70
MORPHINE SULFATE ER 75 39 S2 50 128
KLOR-CON M20 73 62 51 116
CLOPIDOGREL 70 55 52 53
SYNTHROID 69 68 53 59
HYDROCORTISONE 69 53 53 235
LEVOFLOXACIN 68 57 55 89
GALANTAMINE HBR 67 56 56 272
NYSTATIN 66 40 57 228
VESICARE 66 42 57 95
KLOR-CON 10 66 38 57 126
BUPROPION XL 63 13 60 161
HUMALOG 60 49 61 152
OXYBUTYNIN CHLORIDE 60 32 61 88
EVISTA 60 30 61 119
LANTUS 59 42 64 39
SPIRONOLACTONE 59 40 64 42
CRESTOR 59 56 64 28
QUETIAPINE FUMARATE 57 45 67 78
PLAVIX 57 45 67 86
LOVASTATIN 56 37 69 57
CIPROFLOXACIN HCL 55 52 70 60
TERAZOSIN HCL 55 51 70 96
ISOSORBIDE MONONITRATE ER 53 38 72 52
DIOVAN 53 41 72 41
CEPHALEXIN 53 40 72 68
SINGULAIR 53 34 72 106
ALENDRONATE SODIUM 53 52 72 25
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 42 77 91
TRIAMCINOLONE ACETONIDE 51 27 77 102
ACETAMINOPHEN-CODEINE 50 25 S3 79 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.